Page 62 - Amgen News Today

MARKET WRAPS Stocks: European shares fluctuated between minor gains and losses on Thursday, as investors expressed some relief that the Federal Reserves latest monetary policy meeting... -May 02, 2024 at 05:04 am EDT - MarketScreener

Global Wealth Management Investment Advisory Inc. lifted its position in Amgen Inc. (NASDAQ:AMGN – Free Report) by 2.4% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 4,733 shares of the medical research company’s stock after acquiring an additional 109 shares […]

Dive into the world of pioneering entrepreneurs who have reshaped their sectors with groundbreaking ideas, visionary leadership, and tactical prowess. Celebrated for their influential roles in advancing business and innovation,

New York Life Investment Management LLC lowered its stake in Amgen Inc. (NASDAQ:AMGN – Free Report) by 1.0% during the fourth quarter, HoldingsChannel.com reports. The firm owned 76,416 shares of the medical research company’s stock after selling 798 shares during the period. New York Life Investment Management LLC’s holdings in Amgen were worth $22,009,000 at […]

With 50 biosimilar products approved by the FDA, questions arise regarding biosimilar lifecycles and sustainability of the industry.

Futures for stocks in Canada’s largest centre advanced on Thursday boosted by a rise in oil prices as the U.S. Federal Reserve kept the interest rates steady, while positive comments on rates from Bank of Canada Governor Tiff Macklem lifted sentiment. The ...

Wilbanks Smith & Thomas Asset Management LLC reduced its stake in shares of Amgen Inc. (NASDAQ:AMGN – Free Report) by 20.8% during the 4th quarter, according to its most recent filing with the SEC. The firm owned 13,715 shares of the medical research company’s stock after selling 3,592 shares during the period. Wilbanks Smith & […]

ZeroHedge - On a long enough timeline, the survival rate for everyone drops to zero

BioPharma

Drug therapy workups may reveal candidates for immune therapy and provide chance for interventions.